| Document Date: 2009-04-28 14:40:32
Open Document File Size: 49,13 KBShare Result on Facebook
Currency AED / / Event Product Issues / Product Recall / / IndustryTerm healthcare providers / / MedicalCondition ataxia / Myopia / sore throat / Allergic reaction / systemic lupus erythematosus / comatose / headache / CNS depression / seizures / leukopenia / coma / nausea / seizure disorder / Patients Epilepsy / fever / microscopic hematuria / lethargy / Stevens-Johnson syndrome / vomiting / minor seizures / fatigue / drowsiness / urticaria / night terrors / renal disease / epilepsy / hypersensitivity / diarrhea / hirsutism / respiratory depression / infection / dizziness / epigastric and abdominal pain / illness / depression / grand mal seizures / birth defects / cramps / agranulocytosis / eosinophilia / status epilepticus / untreated illness / pancytopenia / / MedicalTreatment adjunctive therapy / Hemodialysis / drug therapy / / Organization DOSAGE AND ADMINISTRATION / / / Position prescribing physician / PRECAUTIONS General / physician / / Product phenytoin / valproic acid / polyethylene glycol / sorbitol / Ethosuximide / anticonvulsant medication / Zarontin / tasks / / Technology alpha / / URL http /
SocialTag |
Zarontin® (Ethosuximide Capsules, USP) DESCRIPTION Zarontin (ethosuximide) is an anticonvulsant succinimide, chemically designated as alpha-ethyl-alphamethyl-succinimide, with the following structural formula: